Member access

4-Traders Homepage  >  Shares  >  Euronext Alternext  >  HYBRIGENICS    ALHYG   FR0004153930

HYBRIGENICS (ALHYG)

383
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on HYBRIGENICS
2013 HYBRIGENICS : Hybrigenics' General Meeting highlights - Focus on inecalcitol rec..
2013 HYBRIGENICS : Update on the clinical study of inecalcitol in chronic lymphocytic..
2013 HYBRIGENICS : Hybrigenics' technology platform applied to the study of the aging..
2013 HYBRIGENICS : Hybrigenics' Technology Platform Successfully Applied to the Study..
2013 HYBRIGENICS : 2012 revenues and update on the clinical study of inecalcitol in c..
2013 HYBRIGENICS : launches a new service to screen interactions between small molecu..
2012 HYBRIGENICS : green ligt for two European patents protecting new oral formulatio..
2012 HYBRIGENICS : launches a new website
2012 HYBRIGENICS : Hybrigenics' first half 2012 revenues of EUR 2 million at the same..
2012 HYBRIGENICS : Hybrigenics' General Meeting Highlights
2012 HYBRIGENICS : Bryan, Garnier & Co initiates coverage of Hybrigenics with a targe..
2012 HYBRIGENICS : Bryan Garnier initiates coverage of Hybrigenics with a target pric..
2012 HYBRIGENICS : completed its private placement to institutional investors up to E..
2012 HYBRIGENICS : gets approval and financing for a phase II clinical trial of oral ..
Advertisement
Chart
Duration : Period :
HYBRIGENICS Technical Analysis Chart | ALHYG | FR0004153930 | 4-Traders
Income Statement Evolution
HYBRIGENICS : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF